Company intelligence / Profile preview

IR Partners

Seoul, Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

IR Partners is a leading investor relations consulting firm based in South Korea, specifically dedicated to the biotechnology and healthcare sectors. Founded in 2011, the company provides specialized IR and PR services, including IPO consulting, investor communication strategies, and market analysis for life science companies. It has played a significant role in the growth of the Korean biotech ecosystem by facilitating capital market entries for numerous high-profile bio-ventures. The firm is recognized as the first IR consulting company in Korea to focus exclusively on the bio-healthcare industry.

Industry: Consulting

Beyond the preview

Go deeper on IR Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IR Partners.

Explore the full profile